Last reviewed · How we verify
Glucagon in MODY (Maturity Onset Diabetes of the Young)
The aim of this study is to determine whether fasting and post-prandial glucagon secretion is suppressed by gliclazide in patients with HNF1-/4-alpha MODY. Participants will undergo an oral glucose tolerance test (OGTT) before and after omitting their gliclazide medication for 3 days.
Details
| Lead sponsor | University of Oxford |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 10 |
| Start date | Mon Jul 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- MODY1
- MODY3
Interventions
- Omission of gliclazide
Countries
United Kingdom